Skip to main content

Advertisement

Table 1 Study groups

From: Effects of hemodynamic monitoring using a single-use transesophageal echocardiography probe in critically ill patients – study protocol for a randomized controlled trial

Study group Hemodynamic monitoring Monitoring interval n
hTEE protocolized monitoring (hTEEPM) • hTEE-guided hemodynamic management
• Additional hemodynamic monitoring of choice of the treating physician
• Study inclusion
• Time of occurrence of new organ system deterioration
• At least every 4 h
125
hTEE standard monitoring (hTEESM) • hTEE-guided hemodynamic management
• Additional hemodynamic monitoring of choice of the treating physician
• Study inclusion
• Follow-up measurement time points at the discretion of the treating physician
• At least every 8 h (standard of care in our ICU)
125
Control protocolized monitoring (ControlPM) • Any hemodynamic monitoring of choice of the treating physician except hTEE • Study inclusion
• Time of occurrence of new organ system deterioration
• At least every 4 h
125
Control standard monitoring (ControlSM) • Any hemodynamic monitoring of choice of the treating physician except hTEE • Study inclusion
• Follow-up measurement time points at the discretion of the treating physician
• At least every 8 h (standard of care in our intensive care unit (ICU))
125